About Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation is a company based in Alachua (United States) founded in 1999 was acquired by Syncona in October 2022. Applied Genetics Technologies Corporation has raised $98.85 million across 10 funding rounds from investors including Syncona, HHS and Alta Partners. The company has 83 employees as of June 30, 2021. Applied Genetics Technologies Corporation offers products and services including AAV Gene Therapy. Applied Genetics Technologies Corporation operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Alachua, United States
- Employees 83 as on 30 Jun, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Applied Genetic Technologies Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation offers a comprehensive portfolio of products and services, including AAV Gene Therapy.
Delivers functional genes to treat genetic retinal diseases effectively.
People of Applied Genetics Technologies Corporation
Unlock access to complete
Unlock access to complete
Funding Insights of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation has successfully raised a total of $98.85M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $444.06 thousand completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Syncona, HHS and Alta Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on healthcare companies
|
Locked | Locked | Locked | |
|
Early-stage investing in IT and healthcare ventures.
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Applied Genetics Technologies Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Applied Genetics Technologies Corporation
Investment portfolio details for Applied Genetics Technologies Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Applied Genetics Technologies Corporation
Detailed financials for Applied Genetics Technologies Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Applied Genetics Technologies Corporation Comparisons
Peer comparison for Applied Genetics Technologies Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
Detailed competitors of Applied Genetics Technologies Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Applied Genetics Technologies Corporation
Complete news archive for Applied Genetics Technologies Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Applied Genetics Technologies Corporation is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
Applied Genetics Technologies Corporation is a funded company, having raised a total of $98.85M across 10 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Applied Genetics Technologies Corporation is 83.
Applied Genetics Technologies Corporation was founded in 1999 in Alachua, United States, within the biotechnology sector. Focus is placed on developing gene therapies for rare ophthalmologic conditions caused by genetic mutations, including lead programs in Achromatopsia, X-Linked Retinoschisis, and X-Linked Retinitis Pigmentosa. An adeno-associated virus-based delivery system is employed for these therapies, targeting orphan diseases in ophthalmology. Operations center on advancing clinical-stage gene therapy solutions.
Applied Genetics Technologies Corporation's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Applied Genetics Technologies Corporation offers AAV Gene Therapy.
Applied Genetics Technologies Corporation has 9 investors. Key investors include Syncona, HHS, Alta Partners, InterWest, and Intersouth Partners.